Leadership Overview
Tolmar has 5 executives leading key functions including finance, operations, medical, legal, and North American commercial strategy.
Driven by innovation, Tolmar is a fully integrated pharmaceutical company dedicated to the development, manufacturing, and commercialization of specialty pharmaceuticals, with a significant focus on Urology, impacting patient care globally.
Driven by innovation, Tolmar is a fully integrated pharmaceutical company dedicated to the development, manufacturing, and commercialization of specialty pharmaceuticals, with a significant focus on Urology, impacting patient care globally.
Leadership Roles at Tolmar
Jeff Lederman - Chief Financial Officer
Jeff Lederman, the Chief Financial Officer at Tolmar, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Lederman ensures robust financial health and compliance across the organization. This leadership role involves managing capital allocation, investor relations, and driving profitability through efficient resource management. By optimizing financial strategies, Jeff Lederman directly supports Tolmar's expansion into new therapeutic areas and global markets. The Chief Financial Officer's oversight extends to risk management and the implementation of financial controls that safeguard company assets and promote sustainable growth. Lederman's expertise is critical in navigating the complex financial landscape of the pharmaceutical industry, ensuring the company's long-term viability and success.
Shawn Silvestri - President & Chief Operating Officer
Shawn Silvestri, the President & Chief Operating Officer at Tolmar, orchestrates the company's day-to-day operations and overall strategic execution. Silvestri drives operational efficiency across all departments, from product development to manufacturing and commercialization, ensuring seamless integration of Tolmar's global functions. This executive position involves optimizing supply chain logistics, enhancing manufacturing processes, and fostering cross-functional collaboration to accelerate product pipelines. By aligning operational strategies with market demands, Shawn Silvestri ensures the effective delivery of specialty pharmaceuticals, including those in Urology. The President & Chief Operating Officer's purview encompasses managing resources, implementing best practices, and championing initiatives that support Tolmar's mission of innovative healthcare solutions. Silvestri's leadership is fundamental to maintaining high standards of quality and productivity across the enterprise.
Steve Griffin - President, North America
Steve Griffin, the President, North America at Tolmar, leads the commercial strategy and execution across the United States and Canada. Griffin directs sales, marketing, and business development initiatives, driving market share growth for Tolmar's specialty pharmaceuticals, including its Urology portfolio. This executive position involves managing regional teams, fostering key stakeholder relationships, and ensuring alignment with global commercial objectives. By optimizing go-to-market strategies, Steve Griffin enhances patient access and commercial success within the North American market. The President, North America's focus extends to identifying new business opportunities and expanding the company's presence through effective product launches and lifecycle management. Griffin's leadership is crucial for achieving revenue targets and solidifying Tolmar's position as a leader in the region.
Anjan Chatterjee - Chief Medical Officer & Chief Marketing Officer
Anjan Chatterjee, the Chief Medical Officer & Chief Marketing Officer at Tolmar, spearheads both clinical strategy and market engagement. Chatterjee directs medical affairs, ensuring the scientific integrity and clinical efficacy of Tolmar's pharmaceutical products, particularly within Urology. Simultaneously, this dual role involves shaping and executing comprehensive marketing strategies to drive product adoption and market penetration. Overseeing clinical research, regulatory affairs liaison, and product lifecycle management, Chatterjee ensures alignment between medical insights and commercial objectives. By translating complex medical data into compelling market narratives, Anjan Chatterjee enhances Tolmar's brand presence and patient outreach. The Chief Medical Officer & Chief Marketing Officer's leadership is pivotal in connecting therapeutic innovation with market needs, fostering growth and patient access to critical treatments.
Michael Elm - Chief Legal Officer
Michael Elm, the Chief Legal Officer at Tolmar, provides strategic legal counsel and oversees all legal affairs for the company. Elm directs corporate governance, intellectual property management, and regulatory compliance, ensuring adherence to stringent pharmaceutical industry standards. This critical role involves managing litigation, negotiating contracts, and advising leadership on legal risks associated with product development, manufacturing, and commercialization. By safeguarding Tolmar's legal interests, Michael Elm supports the company's innovative endeavors and market expansion. The Chief Legal Officer's expertise is essential in navigating the complex legal and regulatory frameworks governing pharmaceutical operations, both domestically and internationally. Elm's guidance is instrumental in maintaining ethical practices and mitigating potential liabilities, thereby securing the company's operational integrity.
Explore Leadership Teams in Manufacturing
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
TU
JS
Lotus Pharmaceutical is a global pharmaceutical company focused on developing, manufacturing, and commercializing generic and specialty medicines. It operates research and manufacturing facilities across Asia and supplies treatments for areas such as oncology, cardiovascular disease, and central nervous system conditions, aiming to improve access to affordable healthcare worldwide.
Company Leadership CK
EC
BS
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB
Parabolic Drugs Limited is a vertically integrated, research-based pharmaceutical manufacturer and exporter, specializing in the production of over 50 active pharmaceutical ingredients (APIs) and intermediates across various therapeutic segments. The company operates four large-scale facilities, including three state-of-the-art manufacturing plants and a custom synthesis and R&D center. With a focus on backward and forward integration, world-class infrastructure, and strong R&D capabilities, Parabolic Drugs is committed to delivering high-quality products. Their diverse product portfolio is supported by intellectual property rights, including Drug Master Files (DMFs) and patents for novel processes.
Company Leadership AN
AJ
VG
YB
Frequently Asked Questions Regarding Tolmar Top Executives and Leadership Team
Unlock more people and company data
